Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)
Go back to Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)| ANACOR PHARM (NYSE: ANAC) | Delayed: 10.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.19 | 52 Week High | $156.93 | |||
| Open | $0.21 | 52 Week Low | $52.00 | |||
| Day High | $10.19 | P/E | N/A | |||
| Day Low | $10.19 | EPS | $-1.54 | |||
| Volume | 31,520 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.82 -1.05 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.87 | 52 Week High | $45.58 | |||
| Open | $49.70 | 52 Week Low | $37.82 | |||
| Day High | $50.06 | P/E | N/A | |||
| Day Low | $49.66 | EPS | $0.00 | |||
| Volume | 1,771,038 | |||||
